Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The genetics of cannabis lifetime use
    Published on 2025-10-03
    2 months ago
  • Transdiagnostic prevention in youth mental health, Part I: rationale, shared risk factors
    Published on 2025-10-02
    2 months ago
  • Inflammatory mechanisms contribute to long-term cognitive deficits induced by perinatal asphyxia via interleukin-1
    Published on 2025-10-02
    2 months ago
  • From symptom-based heterogeneity to mechanism-based profiling in youth ADHD: the promise of computational psychiatry
    Published on 2025-09-30
    2 months ago
  • Digital frontlines: leveraging AI to augment human expertise in crisis and combat situations
    Published on 2025-09-29
    2 months ago
  • Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function
    Published on 2025-09-27
    2 months ago
  • In Memoriam: Terry A. Ketter, MD
    Published on 2025-09-26
    2 months ago
« Previous 1 … 4 5 6 7 8 … 143 Next »
Journal of Psychopharmacology
  • Monoamine oxidase inhibitors: A paradigm of poor science
    Published on 2025-10-04
    2 months ago
  • Modification of natural tryptamines for the treatment of neuropsychiatric diseases
    Published on 2025-10-04
    2 months ago
  • Can cannabinoids alleviate behavioral symptoms in older adults with dementia? A systematic review
    Published on 2025-10-02
    2 months ago
  • Incident benzodiazepine and Z-drug use and subsequent risk of alcohol- and drug-related problems: A nationwide matched cohort study with co-twin comparison
    Published on 2025-10-02
    2 months ago
  • Disrupted network integrity and therapeutic plasticity in drug-naive panic disorders: Insights from network homogeneity
    Published on 2025-10-02
    2 months ago
  • No differences in neural responses or performance during cannabis cue-specific inhibitory control tasks between recreational cannabis users and non-users: Insights from fNIRS
    Published on 2025-10-02
    2 months ago
  • Hypnotics and Suicide: A Tangled Web
    Published on 2025-09-30
    2 months ago
« Previous 1 … 4 5 6 7 8 … 134 Next »
European Neuropsychopharmacology
  • Antipsychotic polypharmacy in patients with schizophrenia between 1999 and 2024 in Denmark: Prevalence, time trends, and combinations
    Published on 2025-08-29
    3 months ago
  • Letter to “Differences in resting-state functional connectivity between depressed bipolar and major depressive disorder patients: A machine learning study”
    Published on 2025-08-28
    3 months ago
  • Letter to the Editor: On clinical predictors of treatment-resistant depression: Comments on validation strategy, predictor independence, and clinical implementation
    Published on 2025-08-26
    3 months ago
  • Strategies for improving research on semaglutide in cocaine use disorder
    Published on 2025-08-26
    3 months ago
  • Letter to the editor: Extrapyramidal symptoms as early clinical predictors in first-episode schizophrenia and schizophreniform disorder: Findings from the OPTiMiSE trial
    Published on 2025-08-26
    3 months ago
  • Intraparietal sulcus depth is associated with negative symptomatology in patients with first-episode psychosis
    Published on 2025-08-26
    3 months ago
  • Do patients benefit from collaborations between industry and academia in psychopharmacological research?
    Published on 2025-08-25
    3 months ago
« Previous 1 … 4 5 6 7 8 … 153 Next »

   Pharma Pub